Astellas Pharma Pink Sheet Forecast - Naive Prediction
| ALPMY Stock | USD 13.91 0.46 3.20% |
Astellas Pink Sheet outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Astellas Pharma's share price is at 59. This suggests that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Astellas Pharma, making its price go up or down. Momentum 59
Buy Extended
Oversold | Overbought |
Using Astellas Pharma hype-based prediction, you can estimate the value of Astellas Pharma from the perspective of Astellas Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 13.80 with a mean absolute deviation of 0.15 and the sum of the absolute errors of 9.32. Astellas Pharma after-hype prediction price | USD 13.91 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Astellas |
Astellas Pharma Additional Predictive Modules
Most predictive techniques to examine Astellas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Astellas using various technical indicators. When you analyze Astellas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Astellas Pharma Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Astellas Pharma on the next trading day is expected to be 13.80 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.04, and the sum of the absolute errors of 9.32.Please note that although there have been many attempts to predict Astellas Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Astellas Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Astellas Pharma Pink Sheet Forecast Pattern
| Backtest Astellas Pharma | Astellas Pharma Price Prediction | Buy or Sell Advice |
Astellas Pharma Forecasted Value
In the context of forecasting Astellas Pharma's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Astellas Pharma's downside and upside margins for the forecasting period are 12.40 and 15.20, respectively. We have considered Astellas Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Astellas Pharma pink sheet data series using in forecasting. Note that when a statistical model is used to represent Astellas Pharma pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.6022 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1503 |
| MAPE | Mean absolute percentage error | 0.0114 |
| SAE | Sum of the absolute errors | 9.3194 |
Predictive Modules for Astellas Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Astellas Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Astellas Pharma After-Hype Price Density Analysis
As far as predicting the price of Astellas Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Astellas Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Astellas Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Astellas Pharma Estimiated After-Hype Price Volatility
In the context of predicting Astellas Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Astellas Pharma's historical news coverage. Astellas Pharma's after-hype downside and upside margins for the prediction period are 12.40 and 15.42, respectively. We have considered Astellas Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Astellas Pharma is not too volatile at this time. Analysis and calculation of next after-hype price of Astellas Pharma is based on 3 months time horizon.
Astellas Pharma Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Astellas Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Astellas Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Astellas Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 1.40 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
13.91 | 13.91 | 0.00 |
|
Astellas Pharma Hype Timeline
Astellas Pharma is presently traded for 13.91. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Astellas is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.49%. %. The volatility of related hype on Astellas Pharma is about 0.0%, with the expected price after the next announcement by competition of 13.91. The book value of the company was presently reported as 861.58. The company last dividend was issued on the 29th of September 2022. Astellas Pharma had 125:100 split on the 2nd of April 2014. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Astellas Pharma to cross-verify your projections.Astellas Pharma Related Hype Analysis
Having access to credible news sources related to Astellas Pharma's direct competition is more important than ever and may enhance your ability to predict Astellas Pharma's future price movements. Getting to know how Astellas Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Astellas Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ORINY | Orion Oyj ADR | 0.00 | 0 per month | 2.43 | 0.04 | 5.28 | (4.51) | 19.91 | |
| GIKLY | Grifols SA ADR | 0.00 | 0 per month | 0.00 | (0.06) | 0.00 | 0.00 | 12.26 | |
| GNMSF | Genmab AS | 0.00 | 0 per month | 1.40 | 0.08 | 3.90 | (3.65) | 10.42 | |
| WXIBF | WuXi Biologics | 0.00 | 0 per month | 0.00 | 0.01 | 2.22 | (1.63) | 9.78 | |
| WXXWY | WuXi Biologics | 0.00 | 0 per month | 2.24 | 0.01 | 4.38 | (3.44) | 13.05 | |
| SBHMY | Sino Biopharmaceutical Ltd | 0.00 | 0 per month | 0.00 | (0.25) | 0.00 | 0.00 | 6.32 | |
| CHJTF | CSPC Pharmaceutical Group | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 22.56 | |
| OTSKF | Otsuka Holdings Co | 0.00 | 0 per month | 0.00 | (0) | 0.64 | 0.00 | 9.16 | |
| SAUHF | Straumann Holding AG | 0.00 | 0 per month | 2.42 | 0.07 | 5.73 | (5.22) | 17.00 | |
| BMXXY | bioMrieux SA | 0.00 | 0 per month | 0.00 | (0.02) | 0.00 | 0.00 | 15.48 |
Other Forecasting Options for Astellas Pharma
For every potential investor in Astellas, whether a beginner or expert, Astellas Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Astellas Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Astellas. Basic forecasting techniques help filter out the noise by identifying Astellas Pharma's price trends.Astellas Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Astellas Pharma pink sheet to make a market-neutral strategy. Peer analysis of Astellas Pharma could also be used in its relative valuation, which is a method of valuing Astellas Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Astellas Pharma Market Strength Events
Market strength indicators help investors to evaluate how Astellas Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Astellas Pharma shares will generate the highest return on investment. By undertsting and applying Astellas Pharma pink sheet market strength indicators, traders can identify Astellas Pharma entry and exit signals to maximize returns.
| Accumulation Distribution | 276.95 | |||
| Daily Balance Of Power | (0.87) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 14.11 | |||
| Day Typical Price | 14.04 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.42) | |||
| Period Momentum Indicator | (0.46) | |||
| Relative Strength Index | 59.25 |
Astellas Pharma Risk Indicators
The analysis of Astellas Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Astellas Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astellas pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.24 | |||
| Semi Deviation | 1.06 | |||
| Standard Deviation | 1.67 | |||
| Variance | 2.79 | |||
| Downside Variance | 2.2 | |||
| Semi Variance | 1.13 | |||
| Expected Short fall | (1.49) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Astellas Pharma
The number of cover stories for Astellas Pharma depends on current market conditions and Astellas Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Astellas Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Astellas Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Astellas Pharma Short Properties
Astellas Pharma's future price predictability will typically decrease when Astellas Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Astellas Pharma often depends not only on the future outlook of the potential Astellas Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Astellas Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 B | |
| Cash And Short Term Investments | 337.3 B |
Additional Tools for Astellas Pink Sheet Analysis
When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.